PATENT CLAIM ANALYSIS

Application Number: 15920519
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates to monovalent influenza vaccine formulations and vaccination regimes for immunising against influenza disease, their use in medicine, in particular their use in augmenting immune responses to various antigens, and to methods of preparation. In particular, the invention relates to monovalent influenza immunogenic compositions comprising an influenza antigen or antigenic preparation thereof from an influenza virus strain being associated with a pandemic outbreak or having the potential to be associated with a pandemic outbreak, in combination with an oil-in-water emulsion adjuvant comprising a metabolisable oil, a sterol and/or a tocopherol such as alpha tocopherol, and an emulsifying agent.

Claim (Index 64):
The method as claimed in  claim 47 , wherein the influenza virus HA antigen of the first or second vaccine composition is derived from cell culture or is produced in embryonic eggs.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.64179
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13163002', '14996446', '12103136', '12596202', '15446508']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8685330139623686
- 35 USC 102 Novelty (BERT): 0.6839717011075844
- Combined Prediction Score: 0.8500768826768902
- Mean Citation Score: 757.982248
- Max Citation Score: 901.9995
- Similarity Product: 674.5660795286893

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test